LabCompass

Peter C. Hollenhorst

Biochemistry, Genetics and Molecular Biology · Indiana University

OpenAlex ORCID
Established · publishing since 2000Rising activity
Renal and related cancersRenal cell carcinoma treatmentProstate Cancer Treatment and ResearchUbiquitin and proteasome pathwaysEpigenetics and DNA Methylation

Publications

233

Citations

3,280

Est. group size

—

Recurring co-author estimate

Active years

27

Publishing since 2000

Research summary
AI-generated

Peter C. Hollenhorst studies how certain gene-regulating proteins called ETS transcription factors drive cancers, particularly prostate cancer, Ewing sarcoma, and kidney (renal cell) cancers. The research examines how these factors interact with other regulatory molecules (such as mutant p53, the PRC2/FOXO1 complex, and AKT signaling) to promote tumor growth, with the goal of identifying vulnerabilities that could be targeted by drugs.

ETS transcription factors in cancerProstate cancer biologyEwing sarcomaRenal cell carcinomaGene regulation and epigenetics

Publication output was modest through the late 2010s and early 2020s, then spiked dramatically in 2023–2024, likely reflecting bundled conference abstracts and supplementary materials, before returning to lower counts.

Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026

Funding
Public award records

No award with a current end date on record.

2 earlier awards
  • NIH R01CA204121May 2017 – May 2023 · $464k awarded

    Molecular mechanisms specific to ETS transcription factors that drive oncogenesis

  • NIH R01CA224342Jan 2018 – Jan 2023 · $460k awarded

    Epigenetic mechanisms of drug resistance in renal cell carcinoma

Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.

In context
Among 1,724 established Biochemistry, Genetics and Molecular Biology PIs within our index
Citations: 3,280cohort median 3,385
h-index: 24cohort median 27
Publications / year (recent): 36.2cohort median 4.6

Typically publishes in teams of ~12 · 11% small-team papers (≤3 authors) · across 23 venues

Publication cadence
Publications per year over the last 10 years — averaging 36.2/year recently
2017: 7 publications172018: 9 publications182019: 4 publications192020: 3 publications202021: 3 publications212022: 1 publication222023: 47 publications232024: 120 publications120242025: 5 publications252026: 8 publications26
Collaborators per year
Distinct co-authors at Indiana University each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
2017: 0 collaborators at the same institution2018: 0 collaborators at the same institution2019: 0 collaborators at the same institution2020: 2 collaborators at the same institution2021: 0 collaborators at the same institution2022: 0 collaborators at the same institution2023: 0 collaborators at the same institution2024: 0 collaborators at the same institution2025: 0 collaborators at the same institution1719212325
Recent publications
Publishes in
  • Cancer Research×17
  • Journal of Biological Chemistry×3
  • PMC×3
  • Clinical Cancer Research×2
  • NAR Cancer×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Sep 1, 2026.

Claim or correct this profile